FeesSafety
Pluang+

Ethereum delays Glamsterdam test on Hoodi due to smart contract compatibility concerns.

Protocol Fundamentals
16 Nov 2026, 01:00 WIB
NewsBTC
View Source
Bearish
Ethereum delays Glamsterdam test on Hoodi due to smart contract compatibility concerns.

Ethereum developers have postponed the planned Glamsterdam network activation on Hoodi, originally set for October 26. The delay is to allow further investigation into how the new EIP-8037 proposal interacts with existing smart contracts. This pause is important to ensure network stability and compatibility before proceeding. The team will resume the activation once these compatibility questions are resolved.

The story on MegaETH's staffing cuts and AI ambitions is presented here with Pluang's cryptocurrency market data for context. For readers following major cryptocurrencies, 41 of 50 priced assets rose while 8 fell. Notable performers include SUSHI at Rp2.828 (+6.30%), VET at Rp88 (+5.92%), and GRT at Rp307 (+5.80%). This snapshot is as of Nov 16, 2026 04:51 WIB.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
32 minutes ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
1 hour ago
All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

Market News
Bullish
5 hours ago
Tesla and SpaceX lose $420B in market value after Democrats win midterms amid probe fears

Tesla and SpaceX lose $420B in market value after Democrats win midterms amid probe fears

Tesla and SpaceX saw a combined market value drop of over $420 billion within two days following the Democratic Party's sweep in the midterm elections. Investors are concerned that the new Democratic-controlled Congress may initiate investigations in...

Bearish
5 hours ago
US spot Bitcoin ETFs see $1.07B outflows amid Bitcoin's 15% weekly price drop

US spot Bitcoin ETFs see $1.07B outflows amid Bitcoin's 15% weekly price drop

US spot Bitcoin ETFs experienced $1.07 billion in net outflows from Nov. 9 to Nov. 13, marking the second consecutive week with over $1 billion in redemptions. BlackRock's iShares Bitcoin Trust (IBIT) accounted for about 85% of these outflows and has...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App